A scoping review shows machine learning models may help predict response to biologic and targeted synthetic DMARDs in ...
TrialTranslator uncovers the survival gap for high-risk patients and offers a path to better cancer research. Study: Evaluating generalizability of oncology trial results to real-world patients using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback